Findings

What do systematic reviews say?

3 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 6 · 100%High 0 · 0%

Angiotensin receptor blockers (ARBs) vs angiotensin‐converting enzyme inhibitors (ACEis)

Residual kidney function (12 months) · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Moderate

Angiotensin receptor blockers (ARBs) vs conventional therapy

Residual kidney function (24 months) · patients receiving PD

4 findings from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Moderate
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Moderate
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 110 participants
Moderate

Show 1 more finding

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 66 participants
Moderate

Angiotensin receptor blockers (ARBs) vs conventional therapy

Residual kidney function (12 months) · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Moderate